Abstract
Alzheimer's disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood-brain barrier. Nanotechnological treatment methods, which involve the design, characterization, production, and application of nanoscale drug delivery systems, have been employed to optimize therapeutics. These nanotechnologies include polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, microemulsion, nanoemulsion, and liquid crystals. Each of these are promising tools for the delivery of therapeutic devices to the brain via various routes of administration, particularly the intranasal route. The objective of this study is to present a systematic review of nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Keywords
Drug deliveryBioavailabilitySolid lipid nanoparticleNasal administrationDrugNanotechnologyPharmacologyBlood–brain barrierMedicinePharmaceutical sciencesMaterials scienceInternal medicineCentral nervous system
Affiliated Institutions
Related Publications
<i>110th Anniversary</i>: Nanoparticle Mediated Drug Delivery for the Treatment of Alzheimer’s Disease: Crossing the Blood–Brain Barrier
Alzheimer's disease is an irreversible neurodegenerative disorder affecting approximately 6 million Americans, 90% of which are over the age of 65. The hallmarks of the disease ...
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
Lipid-based drug delivery systems, or lipidic carriers, are being extensively employed to enhance the bioavailability of poorly-soluble drugs. They have the ability to incorpora...
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital compon...
Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery
Therapeutic proteins and peptides have revolutionized treatment for a number of diseases, and the expected increase in macromolecule-based therapies brings a new set of challeng...
Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy
Oral chemotherapy has been emerging as a hopeful therapeutic regimen for the treatment of various cancers because of its high safety and convenience, lower costs, and high patie...
Publication Info
- Year
- 2015
- Type
- review
- Volume
- 10
- Pages
- 4981-4981
- Citations
- 288
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
288
OpenAlex
Cite This
Bruno Fonseca‐Santos,
Marlus Chorilli,
Maria Palmira Daflon Gremião
(2015).
Nanotechnology-based drug delivery systems for the treatment of Alzheimer&rsquo;s disease.
International Journal of Nanomedicine
, 10
, 4981-4981.
https://doi.org/10.2147/ijn.s87148
Identifiers
- DOI
- 10.2147/ijn.s87148